Aims-To study the expression and importance (if any) of p53 protein in gall bladder carcinoma and its precursor lesions. Methods-Immunohistochemical staining was performed on formalin fixed, paraffin wax embedded histological sections with an anti-human p53 monoclonal antibody (DO-7; Dako Corporation M7001) (24 carcinomas, one adenocarcinoma in situ, six dysplasias, three adenomas and four cases of chronic cholecystitis). Invasive, in situ, and dysplastic areas as well as normal-looking epithelium were sought. Nuclear Carcinogenesis is a multistep process involving several genetic changes which include activation of cellular proto-oncogenes and inactivation of tumour suppressor genes.7
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Invasive carcinomas of the gall bladder are often associated with dysplasia and adenocarcinoma in situ changes in the neighbouring epithelium. This association implies a temporal progression or radical change in the process of carcinogenesis and provides a good sequential model for studying the evolution of p53 protein expression in the malignant transformation of gall bladder epithelium.
Methods
Twenty four carcinomas of the gall bladder, one adenocarcinoma in situ, six epithelial dysplasias, three adenomas and four cases of chronic cholecystitis were retrieved from the files of the department of pathology, National University Hospital. All the tissue had been fixed in 10% buffered formalin and embedded in paraffin wax. Slides stained with haematoxylin and eosin and periodic acid-Schiff before and after diastase digestion were evaluated. The cases were analysed for invasive, in situ, and dysplastic areas as well as normallooking epithelium.
Immunohistochemical staining was performed using a streptavidin-biotin immunoperoxidase method. Waxed sections (4 im) were treated with 3% hydrogen peroxide for 10 minutes to block endogenous peroxidase. The sections were then incubated with 5% bovine serum albumin (BSA) in TRISbuffered saline (TBS) for 30 minutes to eliminate any non-specific staining. Excess BSA was drained from the slides before incubation with an anti-human p53 monoclonal antibody (DO-7; Dako Corporation M7001) at an optimal dilution of 1 in 50 in 0-1% BSA overnight at 4°C. The for one hour at room temperature. After washing with TBS the sections were incubated with peroxidase conjugated streptavidin (Dako; K9000), 1 in 400 in TBS (pH 7 6) for one hour at room temperature. Finally, the sections were developed in diaminobenzidine in hydrogen peroxide substrate with 50 mg of imidazole (Sigma chemicals; I-0250) for 10 minutes. The sections were counterstained with Gill's haematoxylin. A negative control for immunostaining was carried out by replacing the primary antibody with non-immune rabbit serum. A gastric carcinoma known to be p53 positive was used as a positive control. In the analysis of p53 immunoreactivity, only nuclear staining was regarded as specific staining. The intensity of staining in the respective areas of invasive carcinoma, in situ carcinoma, dysplasia, adenomatous change, and histologically normal epithelium was graded as either absent (0), weak (+), moderate (+ +), or strong (+ + +). The extent of staining was semiquantitatively evaluated and categorised as <10%, 10%, and 50%, and >50% of positive cells. Both variables were each graded on a scale of 1-3 and aggregate p53 scores were obtained (range 0, 2-6). Only p53 scores of > 3 were regarded as significant.
Categorical data were assessed using Fisher's exact probability test (one-sided). Probability values of <0 05 were considered significant.
Results Table 1 shows the extent and intensity of p53 protein expression in gall bladder neoplasia. Table 2 shows p53 scores in various lesions of the gall bladder.
NORMAL EP1THELIUM
Normal-looking epithelium, which was present in all cases of chronic cholecystitis (n = 4), protein might have been stabilised by other growth factors involved in gall bladder neoplasia and have become immunohistochemically detectable. This might also explain why two of the adenomas stained slightly. On the other hand, strong staining was seen in some cases of dysplasia-in case 15 the dysplastic areas had the maximum score of 6. This suggests that we are detecting mutated p53 protein, implying that p53 mutations had already occurred. This finding lends further support to the observation that dysplasia is a precursor lesion to gall bladder carcinoma.
In conclusion, the aberrant expression of the p53 gene product is probably involved in the neoplastic transformation of gall bladder epithelial cells. Further studies of patients with gall bladder dysplasias are required to determine whether p53 expression could be used as a marker of disease progression from dysplasia to invasive carcinoma.
